Skip to main content

Table 6 Adverse events in the DTD group and the OE group

From: A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study

 

DTD group

(n = 126)

OE group

(n = 120)

P value

Total

32 (25.4)

34 (28.3)

0.603

Nausea/vomiting

2 (1.6)

4 (3.3)

0.437†

Abnormal taste

22 (17.5)

18 (15.0)

0.601

Diarrhea

7 (5.6)

5 (4.2)

0.613

Abdominal pain

3 (2.4)

2 (1.7)

1.000†

Skin rash

1 (0.8)

2 (1.7)

0.614†

Others

2 (1.6)

5 (4.2)

0.272†

Discontinued drugs because of adverse events

2 (1.6)

3 (2.5)

0.678†

  1. Adverse events were evaluated in modified intention-to-treat
  2. DTD, day-to-day; OE, outpatient education; †, Fisher’s exact test